Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...
Morning Overview on MSN
AI blood test spots early pancreatic cancer with up to 94% accuracy
Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...
Morning Overview on MSN
Scientists want to stop cancer decades before it starts, here's how
A growing body of research is pushing cancer science toward a radical shift: detecting and stopping the disease years or even ...
Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments have been game-changers for lung cancer and skin cancer, prostate cancer ...
In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...
Research has uncovered a surprising biological twist: molecules that help support healthy aging can also contribute to cancer growth.
Where you live has a relationship to your odds of getting cancer and surviving cancer. Epidemiologists studying this link they see in the data have focused on so-called social determinants of health — ...
Scientists at Duke-NUS Medical School have identified a molecular “switch” that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results